Go Ad-Free
My Alerts
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
MARKETS

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

| BSE 1168.90 -43.40 (-3.58%) | |

BSE Live

Feb 01, 16:01
1168.90 -43.40 (-3.58%)
Volume
AVERAGE VOLUME
5-Day
171,636
10-Day
90,925
30-Day
50,727
25,858

  • Prev. Close

    1212.30

  • Open Price

    1215.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 01, 15:57
1172.10 -35.60 (-2.95%)
Volume
AVERAGE VOLUME
5-Day
2,097,435
10-Day
1,394,344
30-Day
1,062,552
744,670

  • Prev. Close

    1207.70

  • Open Price

    1208.00

  • Bid Price (Qty.)

    1172.10 (1535)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Cash Flow of Aurobindo Pharma (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 2,167.85 1,532.52 374.11 108.23 798.52  
Net CashFlow From Operating Activities 1,236.81 646.28 274.87 326.21 335.11  
Net Cash Used In Investing Activities -1,408.51 -818.74 -246.34 -563.12 -599.07  
Net Cash Used From Financing Activities 93.21 117.64 108.09 118.85 406.98  
Foreign Exchange Gains / Losses 1.51 0.11 0.47 -0.01 -0.08  
Adjustments On Amalgamation Merger Demerger Others 379.52 0.00 0.00 0.00 -3.95  
Net Inc/Dec In Cash And Cash Equivalents 302.54 -54.71 137.09 -118.07 138.99  
Cash And Cash Equivalents Begin of Year 148.02 202.73 65.64 183.71 44.72  
Cash And Cash Equivalents End Of Year 450.56 148.02 202.73 65.64 183.71  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347